scanX
Home
Ambalal Sarabhai Enterprises

Ambalal Sarabhai Enterprises

57.15
-2.42
(-4.06%)
Market Cap (₹ Cr.)
₹457
52 Week High
77.70
Book Value
₹18
52 Week Low
37.54
PE Ratio
34.24
PB Ratio
3.25
PE for Sector
40.63
PB for Sector
4.15
ROE
4.14 %
ROCE
7.04 %
Dividend Yield
0.00 %
EPS
₹1.54
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
0.60 %
Net Income Growth
-50.00 %
Cash Flow Change
-17.48 %
ROE
-52.63 %
ROCE
-42.90 %
EBITDA Margin (Avg.)
-21.18 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
15
96
3
2
2
1
3
1
3
1
1
4
20
1
1
1
3
3
2
4
16
2
2
1
25
31
1
1
7
4
3
4
4
3
3
2
4
3
6
Expenses
5
6
12
5
6
4
5
3
11
3
3
2
14
3
2
2
2
2
2
3
1
1
2
2
34
17
1
1
17
3
2
2
2
5
2
2
2
2
2
EBITDA
10
90
-9
-2
-4
-3
-2
-2
-7
-1
-2
1
5
-2
-1
-1
1
1
0
1
15
0
0
-1
-9
14
-0
-0
-10
1
1
2
1
-2
1
-0
3
1
5
Operating Profit %
-166 %
-205 %
-424 %
-141 %
-622 %
-1,215 %
-1,041 %
-1,112 %
-1,875 %
-1,317 %
-810 %
-1,900 %
-4,129 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
-12,677 %
-124 %
-141 %
-91 %
-551 %
-185 %
-166 %
-491 %
-67 %
-111 %
0 %
Depreciation
1
13
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
-1
0
1
1
0
1
0
0
1
1
0
0
-0
0
0
0
-0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
10
77
-11
-3
-5
-4
-3
-3
-9
-2
-2
1
6
-2
-1
-1
1
1
0
1
15
0
0
-1
-9
14
-0
-0
-10
1
1
2
1
-2
1
-0
3
1
5
Tax
0
9
0
0
3
0
0
-1
3
0
0
0
3
0
0
0
0
0
0
0
-0
0
0
0
0
0
0
0
-0
0
0
0
0
0
0
0
-2
0
0
Net Profit
10
68
-11
-3
-8
-4
-2
-2
-12
-2
-1
1
1
-2
-2
-1
1
1
0
1
14
0
0
-1
-9
14
-0
-0
-10
1
1
2
1
-2
1
-1
5
1
4
EPS in ₹
1.33
8.84
-1.44
-0.43
-1.01
-0.54
-0.30
-0.26
-1.62
-0.30
-0.16
0.19
0.58
-0.28
-0.25
-0.09
0.11
0.09
0.06
0.11
1.77
0.02
0.01
-0.10
-1.17
1.79
-0.02
-0.02
-1.36
0.11
0.07
0.21
0.15
-0.26
0.07
-0.08
0.62
0.06
0.56
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
137
144
116
131
139
125
100
83
80
81
Fixed Assets
43
21
16
15
15
15
14
13
13
13
Current Assets
32
40
21
46
54
43
49
43
34
37
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
Investments
0
0
76
56
56
56
27
26
26
25
Other Assets
94
123
24
60
68
54
60
45
41
43
Total Liabilities
137
144
116
131
139
125
100
83
80
81
Current Liabilities
127
91
83
100
112
82
68
48
42
41
Non Current Liabilities
6
4
3
3
2
2
2
1
0
0
Total Equity
3
49
30
29
25
40
31
34
38
40
Reserve & Surplus
-74
-28
-46
-48
-52
-36
-46
-43
-39
-36
Share Capital
77
77
77
77
77
77
77
77
77
77
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
3
-3
1
-1
0
5
-4
-2
0
Investing Activities
13
75
9
26
2
5
16
21
1
4
Operating Activities
-12
-69
-4
-13
-3
-5
-10
-8
2
-4
Financing Activities
-1
-3
-8
-12
-0
-0
-0
-17
-4
0
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
30.76 %
30.76 %
30.76 %
30.76 %
30.76 %
30.76 %
30.76 %
30.77 %
30.77 %
30.77 %
30.77 %
30.77 %
30.77 %
30.77 %
31.35 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
45.73 %
61.63 %
62.64 %
62.38 %
62.42 %
62.23 %
62.18 %
62.12 %
61.64 %
61.54 %
60.76 %
59.46 %
57.92 %
57.93 %
57.59 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,808.85 4,37,470.70 39.03 49,887.20 12.06 9,648 27.34 50.79
Cipla
1,472.05 1,21,662.90 26.34 26,520.70 14.17 4,155 12.95 46.11
Mankind Pharma
2,805.20 1,15,828.20 54.73 10,615.60 19.57 1,942 28.89 61.57
Dr Reddys Laboratories
1,343.65 1,10,601.40 20.73 28,905.40 12.36 5,578 -9.47 69.74
Zydus Life Science
973.50 99,174.40 23.19 19,831.50 13.82 3,831 14.57 47.78
Lupin
2,150.70 98,655.70 37.56 20,141.50 19.94 1,936 73.53 56.33
Aurobindo Pharma
1,241.70 72,873.20 20.17 29,559.20 17.55 3,169 8.66 44.58
Alkem Laboratories
5,427.50 65,692.00 30.23 12,978.40 9.84 1,812 14.16 41.78
Glenmark Pharmaceuticals
1,541.65 43,479.60 - 12,653.10 6.58 -1,831 675.49 48.06
Biocon
335.95 42,063.00 30.18 15,621.20 35.25 1,298 -84.31 38.88

Corporate Action

Technical Indicators

RSI(14)
Neutral
42.58
ATR(14)
Volatile
3.30
STOCH(9,6)
Neutral
38.47
STOCH RSI(14)
Oversold
7.16
MACD(12,26)
Bearish
-0.39
ADX(14)
Weak Trend
16.89
UO(9)
Bullish
29.33
ROC(12)
Downtrend And Accelerating
-1.00
WillR(14)
Oversold
-96.02
Bearish
2
Neutral
5
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Intraday Screeners
Candlestick Screeners
Fundamental Screeners
Technical Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.